Novel antitumor agents CI-920,PD113,270 and PD113,271. I. Taxonomy, fermentation and biological properties.

Josefino B. Tunac, Danielle Graham, W. E. Dobson

The Journal of Antibiotics · 1983 · 103 citations · 9 references

DOIFull text

Open access

Concepts

Abstract

CI-920 (PD 110,161) and two analogues (PD 113,270 and PD 113,271) are novel antitumor compounds produced by a new actinomycete characterized as Streptomyces pulveraceus subsp. fostreus ATCC 31906. The antitumor compounds are predominantly produced during the stationary (idiophase) growth phase of the organism. CI-920 is active versus the murine P388 lymphocytic and L1210 lymphoid leukemia with T/C values of 246 and 207, respectively. This compound has no significant antimicrobial activity.

References

9